News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

July 2015

Top

Eisai’s Lenvima gets FDA breakthrough therapy status for renal cell carcinoma
31 July 2015 Japanese drugmaker Eisai's US subsidiary has obtained breakthrough therapy status from the US Food and Drug Administration (FDA) for its anticancer agent Lenvima (lenvatinib mesylate) to...

AbbVie receives European approval for Humira to treat hidradenitis suppurativa
31 July 2015 AbbVie has received approval from the European Commission (EC) for its Humira (adalimumab) to treat moderate-to-severe hidradenitis suppurativa (HS or acne inversa), which is a painful and...

Hikma to buy Boehringer’s Roxane generic units for $2.65bn
30 July 2015 Hikma Pharmaceuticals has agreed to purchase Roxane Laboratories and Boehringer Ingelheim Roxane (together Roxana) from Boehringer Ingelheim for around $2.65bn....

Merck to acquire Israel’s cCAM Biotherapeutics for $605m
30 July 2015 US-based Merck has signed an agreement to acquire Israel-based biopharmaceutical firm cCAM Biotherapeutics for around $605m....

NICE limits use of BMS's Daklinz to treat hepatitis C infection in UK
29 July 2015 The National Institute for Health and Care Excellence (NICE) has limited the use of Bristol-Myers Squibb's (BMS) Daklinza (daclatasvir) to treat adult patients with chronic hepatitis C infection...

Genzyme to acquire AstraZeneca’s rare disease medicine Caprelsa for $300m
29 July 2015 AstraZeneca has signed an agreement with Genzyme to sell its rare disease medicine Caprelsa (vandetanib) for around $300m....

Sanofi and Regeneron partner to develop new antibody cancer treatments
28 July 2015 Sanofi has partnered with Regeneron Pharmaceuticals to discover, develop and commercialise new antibody cancer treatments in the field of immuno-oncology....

Israel’s Teva to buy Allergan Generics for $40.5bn
28 July 2015 Israel's Teva Pharmaceutical Industries has entered an agreement with Allergan to acquire its generic drug unit Allergan Generics for around $40.5bn....

Ireland’s Allergan to buy drugmaker Naurex for $560m
27 July 2015 Irish pharmaceutical firm Allergan has signed an agreement to acquire clinical-stage biopharmaceutical company Naurex for around $560m....

Baxalta acquires Oncasper portfolio for $900m
24 July 2015 US-based Baxalta has purchased Oncasper (pegaspargase) portfolio from Sigma-Tau Finanziaria for around $900m....

Lupin to buy Gavis Pharmaceuticals for $880m
24 July 2015 Indian drugmaker Lupin has signed an agreement to acquire US-based Gavis Pharmaceuticals and Novel Laboratories (Gavis) for around $880m....

CHMP recommends GSK’s Mosquirix vaccine to prevent malaria in young children
24 July 2015 GlaxoSmithKline (GSK) has received a positive scientific opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for its malaria candidate...

Novartis and Genmab seek FDA approval for ofatumumab to treat relapsed CLL
23 July 2015 Novartis and Genmab are seeking approval from the US Food and Drug Administration (FDA) for their ofatumumab (Arzerra) as maintenance therapy for patients with relapsed chronic...

Horizon increases offer to buy pain treatments maker Depomed
23 July 2015 Irish firm Horizon Pharma has increased its offer to acquire US-based Depomed, which produces products to treat pain and other central nervous (CNS) system conditions....

Novartis's Sandoz cleared to launch generic version of Amgen’s Neupogen
22 July 2015 Novartis's subsidiary Sandoz has been cleared to launch its biosimilar Zarxio (filgrastim) in September, after the US Court of Appeals for the Federal Circuit declined Amgen's claims....

BMS receives European approval for Nivolumab to treat metastatic SQ NSCLC
22 July 2015 Bristol-Myers Squibb (BMS) has received approval from the European Commission for its Nivolumab BMS to treat locally advanced or metastatic squamous (SQ) non-small cell lung cancer (NSCLC)...

Delcath’s melphalan gets FDA orphan drug status to treat cholangiocarcinoma
21 July 2015 Specialty pharmaceutical firm Delcath Systems has obtained orphan drug status from the US Food and Drug Administration (FDA) for its melphalan to treat cholangiocarcinoma....

UK researchers repair damaged liver using stem cells
21 July 2015 Researchers from the UK Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh have successfully repaired damaged liver in a mouse through transplanting...

Valeant to buy Amoun Pharmaceutical for $800m
20 July 2015 Canada-based Valeant Pharmaceuticals International has signed an $800m agreement to purchase Mercury (Cayman) Holdings, the holding firm of Amoun Pharmaceutical....

AbbVie and C2N’s humanised anti-tau antibody obtains FDA orphan drug status for PSP
20 July 2015 AbbVie and C2N Diagnostics have received orphan drug designation from the US Food and Drug Administration (FDA) for their investigational recombinant humanised anti-tau antibody,...

Tillotts completes acquisition of AstraZeneca’s Entocort rights outside US for $215m
17 July 2015 Zeria Group's subsidiary Tillotts Pharma has completed the acquisition of AstraZeneca’s Entocort (budesonide) global rights outside the US for around $215m....


cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1243308781_ap1243308781_1857678299_874850511